Merck KGAAs Acquisition of Bio Techne Set for Late 2026 Completion

Bio-Techne Corp, a leading provider of biotech products and services, has announced that it will be acquired by Merck KGaA. According to the announcement made on June 25, 2026, the acquisition is expected to close by late 2026 or early 2027.

Bio-Techne specializes in producing proteins, immunoassays, clinical diagnostic controls, and other reagents essential for various industries including academia, biopharmaceuticals, and diagnostics. This acquisition marks a significant development in the life sciences sector, with both companies set to benefit from their combined expertise.